News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
669,654 Results
Type
Article (64538)
Company Profile (202)
Press Release (604914)
Section
Business (180690)
Career Advice (2797)
Deals (33620)
Drug Delivery (105)
Drug Development (79539)
Employer Resources (152)
FDA (15490)
Job Trends (14722)
News (317189)
Policy (30922)
Tag
2024 BioCapital Digital (2)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (5)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (14)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (7)
2025 Lone Star Bio Digital (2)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2935)
Academic (2)
Accelerated approval (3)
Adcomms (24)
Allergies (81)
Alliances (45263)
ALS (83)
Alzheimer's disease (1328)
Antibody-drug conjugate (ADC) (101)
Approvals (15484)
Artificial intelligence (238)
Autoimmune disease (16)
Automation (14)
Bankruptcy (297)
Best Places to Work (11674)
BIOSECURE Act (18)
Biosimilars (98)
Biotechnology (149)
Bladder cancer (59)
Brain cancer (27)
Breast cancer (245)
Cancer (1924)
Cardiovascular disease (148)
Career advice (2367)
Career pathing (32)
CAR-T (146)
Cell therapy (403)
Cervical cancer (17)
Clinical research (64244)
Collaboration (744)
Compensation (322)
Complete response letters (23)
COVID-19 (2657)
CRISPR (40)
C-suite (216)
Cystic fibrosis (103)
Data (1855)
Decentralized trials (2)
Denatured (27)
Depression (37)
Diabetes (248)
Diagnostics (6294)
Digital health (18)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (112)
Drug pricing (101)
Drug shortages (27)
Duchenne muscular dystrophy (74)
Earnings (63297)
Editorial (36)
Employer branding (18)
Employer resources (134)
Events (99946)
Executive appointments (659)
FDA (16578)
Featured Employer (46)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (691)
Gene editing (103)
Generative AI (21)
Gene therapy (284)
GLP-1 (710)
Government (4619)
Grass and pollen (4)
Guidances (46)
Healthcare (19069)
Huntington's disease (20)
IgA nephropathy (22)
Immunology and inflammation (99)
Indications (27)
Infectious disease (2782)
Inflammatory bowel disease (137)
Inflation Reduction Act (8)
Influenza (47)
Intellectual property (85)
Interviews (536)
IPO (15537)
IRA (40)
Job creations (3524)
Job search strategy (1994)
Kidney cancer (9)
Labor market (26)
Layoffs (490)
Leadership (18)
Legal (6946)
Liver cancer (67)
Lung cancer (272)
Lymphoma (126)
Machine learning (2)
Management (54)
Manufacturing (260)
MASH (54)
Medical device (12804)
Medtech (12809)
Mergers & acquisitions (18595)
Metabolic disorders (626)
Multiple sclerosis (69)
NASH (17)
Neurodegenerative disease (76)
Neuropsychiatric disorders (24)
Neuroscience (1791)
NextGen: Class of 2025 (6686)
Non-profit (4585)
Northern California (2187)
Now hiring (15)
Obesity (337)
Opinion (239)
Ovarian cancer (67)
Pain (84)
Pancreatic cancer (74)
Parkinson's disease (124)
Partnered (18)
Patents (197)
Patient recruitment (91)
Peanut (50)
People (60042)
Pharmaceutical (47)
Pharmacy benefit managers (16)
Phase I (20035)
Phase II (28174)
Phase III (20970)
Pipeline (889)
Podcasts (64)
Policy (106)
Postmarket research (2711)
Preclinical (8565)
Press Release (67)
Prostate cancer (92)
Psychedelics (30)
Radiopharmaceuticals (259)
Rare diseases (352)
Real estate (6119)
Recruiting (62)
Regulatory (21288)
Reports (33)
Research institute (2479)
Resumes & cover letters (415)
Rett syndrome (3)
RNA editing (2)
RSV (35)
Schizophrenia (65)
Series A (123)
Series B (79)
Service/supplier (9)
Sickle cell disease (51)
Southern California (1939)
Special edition (12)
Spinal muscular atrophy (152)
Sponsored (28)
Startups (3468)
State (1)
Stomach cancer (10)
Supply chain (52)
The Weekly (35)
United States (19820)
Vaccines (659)
Venture capitalists (34)
Webinars (12)
Weight loss (229)
Women's health (31)
Worklife (17)
Date
Today (151)
Last 7 days (580)
Last 30 days (2832)
Last 365 days (32767)
2025 (7245)
2024 (33990)
2023 (38206)
2022 (48768)
2021 (53618)
2020 (52630)
2019 (46537)
2018 (35419)
2017 (31980)
2016 (31462)
2015 (36830)
2014 (29666)
2013 (26261)
2012 (27563)
2011 (27731)
2010 (26025)
Location
Africa (925)
Alabama (52)
Alaska (6)
Arizona (168)
Arkansas (14)
Asia (39963)
Australia (7075)
California (5071)
Canada (1733)
China (443)
Colorado (225)
Connecticut (261)
Delaware (120)
Europe (92159)
Florida (778)
Georgia (187)
Idaho (58)
Illinois (523)
India (21)
Indiana (286)
Iowa (8)
Japan (133)
Kansas (92)
Kentucky (24)
Louisiana (8)
Maine (59)
Maryland (788)
Massachusetts (3834)
Michigan (211)
Minnesota (317)
Mississippi (2)
Missouri (80)
Montana (30)
Nebraska (23)
Nevada (51)
New Hampshire (60)
New Jersey (1498)
New Mexico (29)
New York (1488)
North Carolina (933)
North Dakota (8)
Northern California (2187)
Ohio (181)
Oklahoma (15)
Oregon (36)
Pennsylvania (1138)
Puerto Rico (10)
Rhode Island (23)
South America (1230)
South Carolina (15)
South Dakota (1)
Southern California (1939)
Tennessee (88)
Texas (777)
Utah (163)
Virginia (129)
Washington D.C. (54)
Washington State (505)
West Virginia (3)
Wisconsin (55)
669,654 Results for "stanford university school of medicine".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Novocure and Stanford School of Medicine to Establish Tumor Treating Fields Research Program
Novocure (NASDAQ: NVCR) today announced it has entered into an agreement with Stanford University to establish the Stanford School of Medicine Tumor Treating Fields (TTFields) Research Program.
October 12, 2023
·
5 min read
Business
The Feinstein Institutes 2024 Ross Prize awarded to Stanford University’s Dr. Michelle Monje
The Feinstein Institutes for Medical Research has selected Michelle Monje, MD, PhD, from Stanford University, to receive the 11th annual Ross Prize in Molecular Medicine for her outstanding contributions to research relating to the neuroscience of cancer and its implications for therapy.
June 11, 2024
·
7 min read
Bio NC
Asensus Surgical Announces St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan to Initiate Senhance Surgery Program
Asensus Surgical, Inc. announced that St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan has entered into an agreement to lease and utilize a Senhance® Surgical System in the Urology and Gastroenterology/General Surgery department.
June 24, 2024
·
5 min read
Biotech Bay
Curiox Biosystems Announces the Establishment of the Curiox Innovation Center for the Curiox C-FREE™ Pluto LT System at Stanford University’s Human Immune Monitoring Center
Curiox Biosystems is pleased to announce the establishment of the Curiox Innovation Center for the Curiox C-FREE™ Pluto LT System at the Human Immune Monitoring Center (HIMC) at Stanford University.
June 25, 2024
·
2 min read
Lone Star Bio
Fullpower®-AI Announces Groundbreaking Sleep Studies Presented at the SLEEP 2024 Conference in Partnership with Stanford Sleep Medicine and UCSF
Fullpower Technologies, in collaboration with Stanford Sleep Medicine and UCSF Department of Psychiatry and Behavioral Sciences, presented two major studies at the SLEEP 2024 conference, furthering our understanding of sleep fragmentation and heart rate variability (HRV) during sleep.
June 5, 2024
·
3 min read
Bridge Biotherapeutics Announces a Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Raul Torres’s Lab at the University of Colorado School of Medicine.
March 26, 2024
·
4 min read
Business
Multiply Labs Announces Upcoming Collaboration with Stanford Medicine’s Laboratory for Cell and Gene Medicine (LCGM) to Deploy Automated Systems For Cell Therapy Manufacturing
Multiply Labs, a robotics company developing industry-leading automated manufacturing systems to produce individualized drugs, today announced its upcoming collaboration with Stanford Medicine’s Laboratory for Cell & Gene Medicine (LCGM) to demonstrate the potential of automation technology for cell therapy manufacturing.
April 23, 2024
·
3 min read
Business
Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
Charles River Laboratories International, Inc. (NYSE: CRL) and National University of Singapore’s (NUS) Yong Loo Lin School of Medicine (NUS Medicine),
March 21, 2024
·
2 min read
Press Releases
Sanofi commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to increase diversity in clinical studies
October 16, 2024
·
5 min read
Drug Development
Secondary Cancer Risk Is Low After CAR T Cell Treatment: Stanford Study
Results of a large Stanford Medicine study, published Wednesday in The New England Journal of Medicine, finds CAR-T therapies carry a low risk of secondary malignancies not related to the T cells.
June 13, 2024
·
2 min read
·
Tristan Manalac
1 of 66,966
Next
